Literature DB >> 50853

Studies on mouse Moloney virus induced tumours: II. Detection of p30 in the serum of mice with Moloney leukaemia by in vitro blocking of complement dependent antibody mediated cytotoxicity.

L B Epstein, R A Knight.   

Abstract

Sera from Balb/c mice bearing Moloney leukaemia block complement dependent antibody mediated cytotoxicity of an antiserum prepared in rats against syngeneic Moloney virus induced lymphomata when either spleen cells from mice bearing Moloney leukaemia (M) or an in vitro line of Moloney virus transformed cells (MSC) are used as targets. This antiserum has been shown to recognize p30, the major internal virion protein, as a cytotoxic target on these cells. Viral particles were identified by electron microscopic examination of pelleted material obtained from leukaemic sera after high speed centrifugation. However, removal of virus did not affect the capacity of the leukaemic sera to absorb cytotoxicity of rat ILR-3 for MSC targets, and only depressed somewhat its ability to absorb activity of the same antisera against M targets. Virus-free leukaemic sera also blocks complement dependent antibody mediated cytotoxicity of an antiserum prepared in goats against the gs3 determinant of p30. This indicates that the material in leukaemic sera responsible for the in vitro block of antibody mediated cytotoxicity was p30. A lesser degree of block was observed with sera obtained from normal Balb/c mice, but the nature of material responsible is as yet undefined.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50853      PMCID: PMC2009437          DOI: 10.1038/bjc.1975.91

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  8 in total

1.  Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.

Authors:  G R Shellam; R A Knight
Journal:  Nature       Date:  1974-11-22       Impact factor: 49.962

2.  Group-specific antigen of murine leukemia viruses in mice of low-leukemic strains.

Authors:  G I Abelev; D A Elgort
Journal:  Int J Cancer       Date:  1970-09-15       Impact factor: 7.396

3.  Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.

Authors:  I Hellström; K E Hellström
Journal:  Int J Cancer       Date:  1969-09-15       Impact factor: 7.396

4.  Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.

Authors:  H O Sjögren; I Hellström; S C Bansal; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1971-06       Impact factor: 11.205

5.  Wild-type gross leukemia virus: classification of soluble antigens (GSA).

Authors:  T Aoki; R B Herberman; P A Johnson; M Liu; M M Sturm
Journal:  J Virol       Date:  1972-12       Impact factor: 5.103

6.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

7.  Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and "postfixation" in uranyl acetate.

Authors:  J G Hirsch; M E Fedorko
Journal:  J Cell Biol       Date:  1968-09       Impact factor: 10.539

8.  Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.

Authors:  L B Epstein; R A Knight
Journal:  Br J Cancer       Date:  1975-05       Impact factor: 7.640

  8 in total
  1 in total

1.  Studies on mouse Moloney virus induced tumours: I. The detection of p30 as a cytotoxic target on murine Moloney leukaemic spleen cells, and on an in vitro Moloney sarcoma line by antibody mediated cytotoxicity.

Authors:  L B Epstein; R A Knight
Journal:  Br J Cancer       Date:  1975-05       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.